期刊文献+

高脂饮食C57BL/6小鼠PAI-1表达及罗格列酮干预效果研究 被引量:1

Research on the expression of PAI-1 in C57BL/6 mice feeding high-fat diet and the effect of rosiglitazone treatment
原文传递
导出
摘要 目的:研究正常体重和肥胖C57BL/6小鼠血浆纤溶酶原激活物抑制物-1(PAI-1)水平、内脏和皮下脂肪组织mRNA的表达情况及罗格列酮(RSG)的干预效果。方法:雄性C57BL/6小鼠按体重随机分为对照组、高脂组和RSG组,分别喂饲不同饲料12周,测定血脂、血清PAI-1水平及附睾、皮下脂肪组织PAI-1mRNA的表达情况。结果:RSG组小鼠体重显著高于高脂组和对照组,RSG干预可降低总甘油三酯水平。高脂组血清PAI-1水平显著高于对照组,RSG干预可降低血清PAI-1水平。3组小鼠附睾脂肪组织PAI-1mRNA表达均显著高于皮下脂肪组织;RSG干预可显著降低皮下脂肪组织PAI-1表达,而对附睾脂肪组织却无明显影响。结论:正常体重与肥胖小鼠血清PAI-1水平及内脏、皮下脂肪组织PAI-1的表达均存在差异,RSG有助于改善血脂、降低血清PAI-1水平及皮下脂肪组织PAI-1 mRNA表达。 Objective: To study the level of serum plasminogen activator inhibitor 1(PAI-1) and expression of PAI-1 mRNA in visceral and subcutaneous adipose tissues of C57BL/6 mice with normal weight or obesity and the effect of rosiglitazone(RSG) treatment. Methods: Male C57BL/6 mice were divided into 3 groups randomly.Mice in control group were fed with chow diet, mice in high-fat group were fed with high fat diet and mice in RSG group were firstly fed with high fat diet for 8 weeks and then supplemented with rosiglitazone for other 4 weeks.12 weeks later,serum total triglyceride,total cholesterol and PAI-1 level were detected and the expression of PAI-1 mRNA in adipose tissues was also measured. Results: The body weight of mice in RSG group was significantly higher than that in high-fat group and control.RSG treatment could decrease serum total triglyceride.High-fat diet could increase serum PAI-1 level,but RSG treatment could decrease PAI-1 level of mice with high fat feeding.The expression of PAI-1 mRNA of epididymal adipose tissues in all groups was all significantly higher than subcutaneous adipose tissues.RSG treatment could decrease the expression of PAI-1 mRNA in subcutaneous adipose tissues,but had no effect in epididymal adipose tissues. Conclusion: The level of serum PAI-1 and the expression of PAI-1 mRNA were different between visceral and subcutaneous adipose tissues in both normal and obese mice.RSG treatment contributed to the decrease of blood lipid,serum PAI-1 level and the expression of PAI-1 mRNA in subcutaneous adipose tissues.
出处 《现代医学》 2011年第6期653-657,共5页 Modern Medical Journal
关键词 血浆纤溶酶原激活物抑制物-1 内脏脂肪 皮下脂肪 罗格列酮 高脂饮食 小鼠 plasminogen activator inhibitor 1 visceral adipose tissue subcutaneous adipose tissue rosiglitazone high-fat diet mice
  • 相关文献

参考文献10

  • 1HE G, PEDERSEN S B, BRUUN J M, et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects[J]. Horm Metab Res, 2003,35 ( 3 ) : 178-182.
  • 2SERRANO R, BARRENETXE J, ORBE J, et al. Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats [ J]. Am J Physiol Regul Integr Comp Physiol, 2009,297 ( 5 ) : R1563- R1569.
  • 3MA L J, MAO S L, TAYLOR K L, et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1 [ J ]. Diabetes,2004,53 (2) : 33i5- 346.
  • 4KUDA O, STANKOVA B, TVRZICKA E, et al. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet [ J ]. J Physiol Pharmacol,2009,60(4) : 135-140.
  • 5HWANG Y C, LEE E Y, LEE W J, et al. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients [ J ]. Metabolism, 2008,57 (4) :479-487.
  • 6李倩,孙书珍,汪翼,李燕,陈瑶,牛娜.饮食、运动和罗格列酮干预对高脂饮食性肥胖大鼠心肌间质重构的影响[J].山东大学学报(医学版),2010,48(5):14-17. 被引量:1
  • 7盛祖龙,胡定波,李荥娟,李艳志,任利群.罗格列酮对高胆固醇血症大鼠心肌脂联素与TNF-α水平的影响[J].东南大学学报(医学版),2010,29(3):315-318. 被引量:1
  • 8MUSTAFFA N, IBRAHIM S, ABDULLAH W Z, et al. Addon rosiglitazone therapy improves plasminogen activity and high-density lipoprotein cholesterol in type 2 diabetes mellitus [J]. Blood Coagul Fibrinolysis,2011,22(6) :512-520.
  • 9LEFEBVRE A M, LAVILLE M, VEGA N, et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects[J]. Diabetes, 1998,47( 1 ) :98-103.
  • 10HAO G H, NIU X L, GAO D F, et al. Agonists at PPAR-gamma suppress angiotensin II induced production of plasminogen activator inhibitor 1 and extracellular matrix in rat cardiac fibroblasts [ J ]. Br J Pharmacol, 2008,153 (7) : 1409-1419.

二级参考文献29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部